Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/120524
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Domínguez García, Àngela |
dc.contributor.author | Ciruela, Pilar |
dc.contributor.author | Hernández, Sergi |
dc.contributor.author | García García, Juan José |
dc.contributor.author | Soldevila, Núria |
dc.contributor.author | Izquierdo, Conchita |
dc.contributor.author | Moraga Llop, Fernando A. |
dc.contributor.author | Díaz Conradi, Álvaro |
dc.contributor.author | Sevilla, Mariona F. de |
dc.contributor.author | González Peris, Sebastià |
dc.contributor.author | Campins, Magda |
dc.contributor.author | Uriona, Sonia |
dc.contributor.author | Martínez Osorio, Johanna |
dc.contributor.author | Solé Ribalta, Anna |
dc.contributor.author | Codina, Gemma |
dc.contributor.author | Esteva, Cristina |
dc.contributor.author | Planes, Ana M. |
dc.contributor.author | Muñoz-Almagro, Carmen |
dc.contributor.author | Salleras, Luis |
dc.date | 2018-03-07T18:46:13Z |
dc.date | 2018-03-07T18:46:13Z |
dc.date | 2017-08-14 |
dc.date | 2018-03-07T18:46:13Z |
dc.identifier.citation | 1932-6203 |
dc.identifier.citation | 673394 |
dc.identifier.uri | http://hdl.handle.net/2445/120524 |
dc.format | 15 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Public Library of Science (PLoS) |
dc.relation | Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0183191 |
dc.relation | PLoS One, 2017, vol. 12, num. 8, p. e0183191 |
dc.relation | https://doi.org/10.1371/journal.pone.0183191 |
dc.rights | cc-by (c) Domínguez García, Àngela et al., 2017 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es |
dc.subject | Pneumococs |
dc.subject | Vacunes |
dc.subject | Infants |
dc.subject | Immunologia |
dc.subject | Streptococcus pneumonia |
dc.subject | Vaccines |
dc.subject | Children |
dc.subject | Immunology |
dc.title | Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |